Glycolipids Market REPORT OVERVIEW
-
Request a Free Sample to learn more about this report
The global glycolipids market size was USD 2920.6 million in 2022 and market is projected to touch USD 4528.3 million by 2031, exhibiting a CAGR of 5.0% during the forecast period.
The global COVID-19 pandemic has been unprecedented and staggering, with glycolipids experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
Glycolipids (GLs), commonly referred to as glycosylated lipids, are lipid derivatives having a substantial potential for value addition. They offer a variety of biological activities with potential medical and cosmeceutical applications in addition to their particular surface activities, which allow many of them to function as excellent ecological detergents. Another form of glycolipid called sophorolipids has been shown to modify immune responses and reduce sepsis-related mortality in animal models. Additionally, glycolipids may impair a bacterial pathogen's ability to adhere to surfaces, making them useful as anti-adhesive agents and in the cosmetics industry for preventing the formation of biofilms. Additionally, they have demonstrated a significant potential for use in the industry as wetting agents, flotation agents, and detergents.
Due to their capacity to lower surface and interfacial tension, glycolipids with reduced molecular weight, such as glycolipids, low-molecular-weight peptides (LPs), and phospholipids, have industrial potential. Trehalolipids, cellobiose lipids, mannosylerythritol lipids, rhamnolipids (mostly from Pseudomonas), and Sophorolipids (SLs) (produced from Candida and related species) are the glycolipids that are most commonly employed. Due to their ability to permeabilize, which causes the bacterial plasma membrane to degrade, glycolipids and rhamnolipids have antibacterial properties. The environmentally friendly biological characteristics of rhamnolipids make them appealing substances for therapeutic applications, and they have attracted a lot of interest in sectors like food, healthcare, pharmaceuticals, and petrochemicals.
COVID-19 IMPACT: Shortages in Raw Material Supply and Demand Chains Impacted Market Growth Negatively
During COVID-19, the glycolipidsmarket growth was greatly impacted in 2020. Flight cancellations, travel bans, and quarantines, restaurant closures, restrictions on all indoor and outdoor events, the declaration of states of emergency in more than 40 countries, a significant slowdown in the supply chain, stock market volatility, a decline in business confidence, rising public panic, and uncertainty about the future are just a few of the effects of the COVID-19 outbreak. These factors impacted PAA scale inhibitor market growth amid the pandemic. Lockdown and shutdown procedures were improved as a result of the COVID outbreak. The following lockdown and closure, which forced businesses to halt their manufacturing operations, had a negative impact on those businesses. While the supply chain experienced noticeable disruption, demand for the finished product declined. In light of the escalating COVID-19 cases, the government took many actions to ensure the protection of everyone in the country.
LATEST TRENDS
"Expanding Scope in Biotech Research & Development to Transform Market Outlook"
One of the most popular low-molecular-weight glycolipids, glycolipids have been extensively studied for their potential applications in biotechnology. In a bio-based economy, microbial glycolipids such as sophorolipids (SLs), rhamnolipids (RLs), and mannosylerythritol lipids (MELs) are attractive substitutes for synthetic glycolipids. Because the fermentation, extraction, and purification processes for these surfactants have significantly improved, numerous biotechnology-based and specialty chemical manufacturers are expanding their production, marketing, and commercialization of microbial-based glycolipid surfactants, particularly rhamnolipid and sophorolipids. As producers create eco-friendly glycolipids, these kinds of biosurfactations are currently becoming more popular on the market.
In order to substitute petrochemical surfactants in personal care formulations, for example, Locus Performance Ingredients, a brand-new start-up that specializes in the production of glycolipids via improved fermentation, introduced its first product line on August 5, 2020. The FermaTM brand of pure sophorolipidglycolipids offers safer and more environmentally friendly ingredient solutions with 5–25 times greater performance, enabling a minimum 37% decrease in carbon footprint. Fermaglycolipids, which are made of sophorolipids, a type of glycolipid, are adaptable, quickly biodegradable, and mild ingredient solutions that enable marketers to streamline product labeling and pioneer a new sustainable component trend in this sector.
Glycolipids Market SEGMENTATION
-
Request a Free Sample to learn more about this report
- By Type Analysis
By Type, the glycolipids market share is segmented into Glycosyl Triacylglycerol, Glycosphingolipid, and Others. The Glycosyl Triacylglycerol segment dominates the market.
- By Application Analysis
By Application the market share is broken down into Food, Nutrition & Supplements, Pharmaceuticals, and Others. The food segment is slated to capture the dominant market share over 2031.
DRIVING FACTORS
"Growing Consumer Awareness Toward Environmental Sustainability to Augment Market Growth"
Growing consumer awareness of microbial glycolipid-based green surfactants that are eco-friendly and sustainable, the development of novel strategies for producing glycolipid glycolipids, and rising demand from the biomedical and cosmetic industries are all significant factors propelling the growth of the glycolipids market. Additionally, a significant driver driving market expansion is the growing commercialization of glycolipids in the form of glycolipids for use in the food, personal care, and oil field industries.
One of the key factors propelling the market's revenue growth is the development of fresh methods pertaining to industrial production processes for glycolipid glycolipids. As an illustration, the project "New processes for fermentative production of glycolipid glycolipids and sialylated carbohydrates," which is a part of the European Commission's Horizon-2020 initiative, aims to develop novel fermentation techniques to produce a variety of glycolipid glycolipids, including rhamnolipids, sophorolipids, xylolipids, and mannosylerythritol-lipids, which have a wide range of applications.
"Increasing Demand from Cosmetics and Personal Care Sector to Drive the Market Growth"
The growing demand from the cosmetics and skincare sectors is a key factor in the growth of this market. In 2021, the cosmetics and personal care segment's revenue increased at a high rate. A successful skincare regimen must have low toxicity, bio-compatibility, skin protection, and surface moisturizing, and glycolipids (glycolipids) have showed a lot of promise in these areas. Glycolipids have vital physiochemical characteristics that are crucial for the health of the skin. Glycolipids support cellular recognition and cell membrane integrity maintenance, two critical components of plant and animal immune responses. It simply makes it possible for skin cells to join together to form tissues.
Further subdivided into rhamnolipids, sophorolipids, trehalose lipids, and mannosylerythritol lipids is the microbial glycolipids segment. Rhamnolipid (RL) and Sophorolipid (SL), two important microbiological glycolipids, are excellent surface tension-lowering glycolipids. To further advance their commercial and economic interests, value-added characteristics, such as bacteriocidal activity, are also added to their surfactant and environmentally friendly capabilities. Both tomato-rotting bacteria (Pseudomonas corrugate) and the acne-causing Propionibacterium acnes were discovered to be very susceptible to these glycolipids' antibacterial properties. The discovery increases the RL and SL compounds' antibacterial activity, potentially increasing the market value of glycolipid glycolipids.
RESTRAINING FACTORS
"High Raw Material Prices and Production Costs Could Hamper Market Development "
However, expensive raw material and purification expenses, as well as lack of economization, have resulted in a drop in glycolipid glycolipid synthesis by microbial fermentation as purification, including raw materials and fermentation, are the most expensive steps in the glycolipid production process, which is slowing market growth. The low glycolipid glycolipidcommercialization and rising production costs restrain market expansion. However, the emergence of cost-effective production methods is projected to present enormous growth prospects for glycolipid glycolipid manufacturers.
Glycolipids Market REGIONAL INSIGHTS
-
Request a Free Sample to learn more about this report
"Europe Holds the Majority of the Market Share Owing to Stringent Environmental Regulations "
In 2022, the Europe market contributed a modest portion of total sales. This is due to a number of causes, including a rise in government-funded research programs for research and development as well as more regulatory approvals and regulations for green surfactants. For instance, the use of long-chain glycolipids produced from Dacryopinaxspathulate (commonly known as AM1) as a food additive has been subject to safety rules from the European Food Safety Authority's (EFSA) Panel on Food Additives and Flavourings (FAF).
Numerous biotechnology and specialty chemical companies in the region are stepping up the marketing and commercialization of microbial-based surfactants, particularly glycolipids like rhamnolipid and sophorolipids, as the fermentation, extraction, and purification processes for these surfactants have significantly advanced in comparison to even a few years ago. Even if the global production volume for microbial surfactants continues to be small, it has been reported that the production yields of these glycolipids have increased and premiums above fossil-based surfactants have decreased.Evonik, a German manufacturer of specialty chemicals, is thinking about building a new large-scale rhamnolipids production facility in anticipation of a big rise in demand for the glycolipids-based surfactant. The new rhamnolipids factory is expected to start producing low double-digit kilotons of rhamnolipids in 2023, according to news reports. The firm, however, has not provided any precise details on its anticipated new rhamnolipids output.
KEY INDUSTRY PLAYERS
"Key Players Focus on Partnerships to Gain a Competitive Advantage "
Prominent market players are making collaborative efforts by partnering with other companies to stay ahead in the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolio.
List of Market Players Profiled
- Archer Daniels Midland
- Cargill Incorporated
- DowDuPont
- Royal DSM
- LIPOID
REPORT COVERAGE
This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 2920.6 Million in 2022 |
Market Size Value By |
US$ 4528.3 Million by 2031 |
Growth Rate |
CAGR of 5% from 2022 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the glycolipids market expected to touch by 2031?
Based on our research, the glycolipids market is projected to touch USD 4528.3 million by 2031.
-
What CAGR is the glycolipids market expected to exhibit by 2031?
The glycolipids market is expected to exhibit a CAGR of 5.0% by 2031.
-
Which are the driving factors of the glycolipids market?
Accelerating research & development in biotechnology is expected to promote glycolipids market growth during the projected period.
-
Which are the top companies operating in the glycolipids market?
Archer Daniels Midland, Cargill Incorporated, DowDuPont, Royal DSM, and LIPOID are among the notable names in the industry.